Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCL8 |
| Upstream (Parents) |
|---|
| (<<) ALOX5AP → CCL8 |
| (<<) LGALS1 → CCL8 |
| (<<) GREM1 → CCL8 |
| (<<) CCL2 → CCL8 |
| (<<) RAB31 → CCL8 |
| Downstream (Children) |
|---|
| CCL8 → TMEM19 (>>) |
| CCL8 → HLA-DRB4 (>>) |
| CCL8 → IL26 (>>) |
| CCL8 → CCL13 (>>) |
| CCL8 → ESR2 (>>) |
| CCL8 → CCL11 (>>) |
| CCL8 → CCL7 (>>) |
| CCL8 → PRDX2 (>>) |
| CCL8 → IL2RA (>>) |
| CCL8 → LY6H (>>) |
